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a b s t r a c t
Background: Pneumonia is a leading cause of morbidity and mortality in children worldwide; however,
its diagnosis can be challenging, especially in settings where skilled clinicians or standard imaging are
unavailable. We sought to determine the diagnostic accuracy of lung ultrasound when compared to
radiographically-confirmed clinical pediatric pneumonia.
Methods: Between January 2012 and September 2013, we consecutively enrolled children aged 2e59
months with primary respiratory complaints at the outpatient clinics, emergency department, and
inpatient wards of the Instituto Nacional de Salud del Ni~no in Lima, Peru. All participants underwent
clinical evaluation by a pediatrician and lung ultrasonography by one of three general practitioners. We
also consecutively enrolled children without respiratory symptoms. Children with respiratory symptoms
had a chest radiograph. We obtained ancillary laboratory testing in a subset.
Results: Final clinical diagnoses included 453 children with pneumonia, 133 with asthma, 103 with
bronchiolitis, and 143 with upper respiratory infections. In total, CXR confirmed the diagnosis in 191
(42%) of 453 children with clinical pneumonia. A consolidation on lung ultrasound, which is our primary
endpoint for pneumonia, had a sensitivity of 88.5%, specificity of 100%, and an area under-the-curve of
0.94 (95% CI 0.92e0.97) when compared to radiographically-confirmed clinical pneumonia. When any
abnormality on lung ultrasound was compared to radiographically-confirmed clinical pneumonia the
sensitivity increased to 92.2% and the specificity decreased to 95.2%, with an area under-the-curve of 0.94
(95% CI 0.91e0.96).
Conclusions: Lung ultrasound had high diagnostic accuracy for the diagnosis of radiographically-
confirmed pneumonia. Added benefits of lung ultrasound include rapid testing and high inter-rater
agreement. Lung ultrasound may serve as an alternative tool for the diagnosis of pediatric pneumonia.
© 2017 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
* Corresponding author. Johns Hopkins University, Division of Pulmonary and Critical Care, 1800 Orleans Ave, Suite 9121, Baltimore, MD 21287, USA.
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1. Introduction
Pneumonia is a leading cause of death in children worldwide. It
is responsible for 120 million episodes and 1 million deaths each
year in children aged <5 years [1,2]. Despite a decrease in child
mortality in the past 20 years, the proportion of pneumonia deaths
has remained constant at approximately 20% [3]. In low resource
settings, where skilled providers are not widely available, the
World Health Organization (WHO) developed a case management
algorithm for the treatment of pneumonia. This involved training
community health workers to identify respiratory signs and
symptoms, centered on cough, difficulty breathing, respiratory rate
and danger signs, for diagnosis, treatment, and referral [5]. While
this algorithm achieved important mortality reductions after
implementation [6], multiple studies thereafter have shown that it
lacks specificity [7e9]. A high false positive rate has resulted in
overuse of antibiotics and improper therapy for childrenwith acute
bronchospasm that may instead require bronchodilators.
Pediatric pneumonia is a heterogeneous disease with bacterial
and viral causes. Additionally, there is a large overlap with bron-
chiolitis and reactive airways disease. Therefore, the diagnosis of
pneumonia can be challenging and requires integration of a variety
of diagnostic tools [9,10]. In low resource settings, previous studies
have tested additional, non-respiratory, diagnostic features, such as
fever [10] and oxygen saturation [11,12]. But when resources are
available, imaging is an important adjunct [13]. In fact, the Amer-
ican Academy of Pediatrics endorsed chest X-ray (CXR) as the im-
aging modality of choice for complicated or ambiguous cases [10].
However, CXR has its own disadvantages including radiation
exposure, high inter-observer variability [14], and lack of impact on
clinical outcome [15].
Lung ultrasound (LUS) is an emerging diagnostic tool for
pneumonia in both adults [16] and children [17]. It also has many
advantages for pediatric respiratory disease in low resource set-
tings, including portability, rapid and repeat testing, no ionizing
radiation, and ease of use [18e20]. We sought to evaluate the
diagnostic accuracy of LUS as a point-of-care diagnostic tool for
pediatric pneumonia in a tertiary care setting in Lima, Peru.
2. Materials and methods
2.1. Study design
Between January 2012 and September 2013, we consecutively
enrolled children with respiratory symptoms in the Emergency
Department, General Pediatric Wards, and Outpatient Clinics at the
Instituto Nacional de Salud del Ni~no; a large children's hospital
treating more than 170,000 children annually, in Lima, Peru. In-
clusion criteria were children aged 2e59 months and the presence
of respiratory symptoms. Exclusion criteria were: chronic lung
disease excluding asthma, significant cardiac disease, and need for
mechanical ventilation. We also enrolled children of a similar age
range without respiratory complaints and acute non-respiratory
illnesses (fever, vomiting or diarrhea) at the same institution.
These children were usually those presenting to the hospital for
well-child visits or siblings of child participants recruited into the
study. We described detailed methods about study procedures
elsewhere [21]. Of note, we amended the original protocol to allow
for an increase in sample size. We followed STARD guidelines for
the reporting of diagnostic accuracy [22]. The study was approved
by the Institutional Review Board committees of the Instituto
Nacional de Salud del Ni~no (Lima, Peru), A.B. PRISMA (Lima, Peru),
and the Johns Hopkins School of Medicine (Baltimore, USA).
2.2. Clinical diagnosis
Clinical assessment included a history and physical exam per-
formed by a pediatrician. Pediatricians on service provided a
diagnosis following standard of care with input from international
clinical guidelines (Table 1) [23e25]. An anteroposterior CXR was
obtained for all children with respiratory symptoms. Lateral view
CXRs were not obtained because they were not consistent with
clinical practice in our setting. CXR used a scanner with
4800  4800 dots-per-inch resolution for CXR image digitation.
Filmswere digitized and sent to a third party reading group of three
study radiologists. We did not obtain a CXR on children without
respiratory symptoms.
2.3. Lung ultrasound imaging
All participants underwent a complete LUS evaluation using a
MicroMaxx® portable ultrasound machine (Sonosite, Bothwell,
WA) with a HFL38/13-6 MHz linear transducer. This device is
approximately the size of a 13” laptop computer and used at the
bedside as a point-of-care tool. One of three general practitioners
(LEE, MAC, and JMC) performed LUS after completing a 7-day
standardized training protocol [21] based on international recom-
mendations [26]. Both conduct and interpretation of LUS findings
were performed independent of clinical evaluation or radiographic
findings. LUS was conducted on almost all childrenwho had CXR as
well as on all children without respiratory symptoms (Fig. 1).
2.4. Imaging interpretation
Interpretation CXR and LUS images was performed at a later
date by three board-certified pediatric radiologists (PCC, EAM, and
JB) and three general practitioners (LEE, MAC, and JMC), respec-
tively. These groups were blinded to clinical information and re-
sults from the alternative imaging modality. We used standardized
protocols for interpretation of both CXR [14] and LUS [26]. We
defined radiographic pneumonia as the presence of a lobar
consolidation with or without a pleural effusion (Table 1). Pneu-
monia on LUS was defined as the identification of artifacts consis-
tent with lobar consolidation or patchy lobar consolidation, if it
occupied more than one intercostal space in vertical view, or small
consolidationwith a pleural effusion (Table 1). We did not consider
the isolated findings of interstitial changes on LUS or CXR as posi-
tive for pneumonia. Agreement by two out of three readers was
required for final diagnosis.
2.5. Laboratory assessment
We conducted laboratory testing in a subset of participants to
offer additional objective data. Complete blood counts and blood
cultures were obtained in a subset of 361 and 137 children,
respectively. Serum or plasma levels of procalcitonin (PCT) were
measured in a convenience sample of 259 children. Batched sam-
ples were maintained at 20 C until tested in a reference labora-
tory. PCT levels were measured using the Kryptor
chemiluminescence immunoassay (BRAHMS, Hennigsdorf, Ger-
many) according to manufacturer specifications. The inter-assay
coefficient of variation was <10%, and the functional sensitivity of
the assay was 0.06 ng/mL. Pharyngeal swabs were analyzed for
viruses and bacteria in a convenience sample of 251 children.
Nucleic acid extraction for viral testing was accomplished utilizing
the Arrow Viral NA kit (Diasorin Inc., Stillwater, MN), while bacte-
rial extraction utilized the MagNA Pure LC with DNA Isolation Kit I
(Roche Diagnostics, Indianapolis, IN). For viral testing, respiratory
virus controls were utilized in each run (NATrol Respiratory
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Validation Panel 3, Zeptometrix Corporation, Buffalo, NY). Reverse
Transcription polymerase chain reaction/Electrospray ionization
mass spectrometry (RT-PCR/ESI-MS, Abbott Molecular, Des Plaines,
IL) was performed for viral and bacterial pathogens with Respira-
tory Virus Surveillance 2.5 kit and the Bacterial Antibiotic Candida
kit. Positive detection were defined as reactions identified by RT-
PCR/ESI-MS as having a Q score >0.9.
2.6. Biostatistical methods
The primary goal of our analysis was to establish the diagnostic
accuracy of sonographically-confirmed pneumonia when
compared to radiographically-confirmed clinical pneumonia as the
reference standard. This comparison was conducted in child par-
ticipants with respiratory findings that were diagnosed with clin-
ical pneumonia by a study physician, and had both CXR and LUS
conducted as part of the study. We focused on clinical pneumonia
only because asthma, bronchiolitis and upper respiratory infection
had low rates of consolidation on CXR. We defined positive sono-
graphic findings as either finding a consolidation or any abnor-
mality on LUS. Any abnormality on LUS was included to show that
there was a difference in diagnostic accuracy between consolida-
tion and any abnormality on LUS, when compared to
radiographically-confirmed clinical pneumonia. Diagnostic accu-
racy was measured using positive predictive value (PPV), negative
predictive value (NPV), sensitivity, specificity and the C-statistic as
a measure of area under the Receiving Operator Characteristic
curve. We analyzed continuous variables as means using analysis of
variance, and categorical variables as proportions using chi-square
or Fisher exact tests, as appropriate. Inter-rater agreement among
readers was determined using the kappa coefficient. We conducted
statistical analyses in R (www.r-project.org) and STATA version 13
(StatCorp, College Station, Texas).
3. Results
3.1. Participant characteristics
From January 2012 to September 2013, 1428 children were
assessed for eligibility (Fig. 1). Of those, 1062 (74%) children un-
derwent LUS. Upon initial assessment, 128 children were found to
be ineligible due to age, and presence of cardiac or chronic respi-
ratory disease, and 163 children without respiratory symptoms
were found to have an acute non-respiratory illness upon further
evaluation. Additionally, 76 ultrasounds were not obtained due to
time constraints or parents refused. Median agewas 19months and
57% were male. The final clinical diagnoses were as follows: 453
had clinical pneumonia, 133 had asthma, 103 had bronchiolitis, 143
had an upper respiratory infection, and 230 were children without
respiratory symptoms (Table 2). CXR identified abnormalities
consistent with pneumonia in 360 (79%) children, and 191 (42%)
were found to have consolidations and 169 (37%) had an interstitial
abnormality.
3.2. Inter-reader agreement
For LUS, kappa coefficients for agreement among readers was
0.65 (95% CI 0.61e0.66) overall, 0.73 (0.70e0.74) for a normal lung
ultrasound, 0.38 (0.27e0.41) for interstitial abnormalities, and 0.77
(0.75e0.78) for lung consolidation. Medium and large consolida-
tion findings yielded a kappa coefficient of 0.87 (0.86e0.89) and
small consolidation yielded a kappa coefficient of 0.77 (0.74e0.81).
For CXR, kappa coefficients for agreement among readers was 0.37
(95% CI 0.34e0.40) overall, 0.40 (0.37e0.42) for normal chest
radiograph, 0.20 (0.16e0.23) for interstitial abnormalities, and 0.51
(0.48e0.58) for lung consolidation.
Table 1
Guidelines for clinical diagnosis and definitions and grading system for lung ultrasound and chest radiograph.
Clinical diagnoses
Pneumonia Difficulty breathing as described by tachypnea, chest indrawing, nasal flaring, or grunting; history of fever, cough, chest pain or abdominal pain;
adventitious lung sounds, including rales, rhonchi, crackles, or diminished sounds. Associated CXR findings of interstitial abnormalities or
consolidation as reviewed by hospital clinician or on-site radiologist at time of diagnosis [3]. Severity was assessed by presence of chest indrawing,
seizures, lethargy, or unconsciousness [4].
Asthma Presence of wheeze or difficulty breathing on physical exam, history of wheeze and responsive to bronchodilators [5]. Response to
bronchodilators assessed clinically without formal pulmonary function testing.
Bronchiolitis Less than 18 months of age; presence of wheeze or coarse breath sounds, difficulty breathing, and viral symptoms (cough, rhinorrhea); not
responsive to bronchodilators if attempted [24].
Upper respiratory
infection
Associated with nasal secretions, nasal congestion, sore or red throat or hoarseness without evidence of lower airways involvement (tachypnea
and abnormal lung sounds on exam).
Lung ultrasound findings
Lung sliding Rhythmic movement of pleural line with respiration. It represents sliding of the visceral pleura against the parietal pleura.
A-lines Horizontal lines equally spaced from pleural line, representing artifact generated by subpleural air, a normal finding.
B-lines Vertical lines arising from pleura and extending to base of the image.
Pleural abnormality Disruption of pleural line.
Consolidation Hypoechoic circumscribed disruption of pleural line extending inferiorly and may contain any of the following; Air bronchogram, Shred sign,
Pleural effusion.
Air bronchogram Punctate or branching hyperechoic images reflecting airways made visible by surrounding fluid/inflammation
Shred sign Irregular border of consolidation
Pleural effusion Anechoic space between visceral and parietal pleura.
Sonographic grading
Lung consolidation
Small Consolidation contained within one intercostal space and extending just below pleural line.
Large Consolidation extends to more than 1 intercostal space, extends beyond the pleural line, and may be associated with a pleural effusion.
Interstitial abnormality
Focal Multiple B lines (3) present in single view or unilaterally.
Diffuse Multiple B lines (3) present bilaterally.
Radiographic grading




Linear and patchy densities in a lacy pattern involving both lungs, featuring peri-bronchial thickening and multiple areas of atelectasis. Lung
inflation is normal to increased.
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3.3. Imaging characteristics
A total of 1062 ultrasounds were available for review. Among
children without respiratory symptoms, none had lung consolida-
tion, and 11 (1%) had an interstitial abnormality. Of the 832 par-
ticipants with respiratory symptoms, 414 (50%) had a sonographic
lung consolidation and 530 (64%) had any abnormality (Table 3). On
average, LUS took less than 10 min to perform; 5.5 ± 2.1 min in
controls compared to 8.2 ± 3.1 min in children with pneumonia
(p < 0.001). We summarized characteristics of LUS findings in
Table 2. A total of 832 CXRs were available for review. Of these, 221
(26%) had a lobar consolidation and 264 (32%) had interstitial
abnormality.
3.4. Diagnostic performance
Consolidation on lung ultrasound had a sensitivity of 88.5%,
specificity of 100%, and AUC of 0.94 (95%CI 0.92e0.97) when
compared with radiographically-confirmed clinical pneumonia
(Table 4). Any abnormality on lung ultrasound had a sensitivity of
92.2%, specificity of 95.2%, and AUC of 0.94 (95% CI 0.91e0.96) with
compared with radiographically-confirmed clinical pneumonia
(Table 5).
3.5. Laboratory findings
We summarized differences in ancillary laboratory data by final
diagnosis status (Table 6). Procalcitonin levels supported our clin-
ical definitions of pneumonia and bronchiolitis, with highest levels
in childrenwith pneumonia. Childrenwith bronchiolitis weremore
likely to have respiratory syncytial virus isolated on a pharyngeal
swab when compared to other groups. Streptococcus pneumoniae
was present in over half of all participants, with no difference found
between children with or without respiratory symptoms. There
were no differences in demographic variables like age and sex be-
tween those with and without ancillary laboratory data (data not
shown).
4. Discussion
Our study supports the use of point-of-care lung ultrasound as a
reliable and accurate method of diagnosing radiographically-
confirmed clinical pediatric pneumonia. LUS averaged less than
10 min to perform with high inter-reader agreement. Moreover,
there is a high diagnostic accuracy between identification of
consolidation on LUS and radiographically-confirmed clinical
pneumonia in children.
Two recent meta-analyses by our group also demonstrated high
accuracy of LUS for the diagnosis of pneumonia in adults [16] and
children [17], however, these analyses were limited by small sam-
ple sizes and heterogeneity among studies, decreasing the overall
power. Moreover, five of the eight studies focused on hospitalized
or critically ill children [28,30,32] or neonates [29,31], and there-
fore lacked generalizability in an outpatient or emergency room
setting. Additionally, sonographers read the LUS at time of clinical
evaluation and therefore were not blinded to clinical information.
Our study has several strengths and contributes novel and
important information. We enrolled >1000 children aged under
Fig. 1. Flowchart of study participants.
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Table 2
Demographic information and clinical characteristics according to study group. Tachycardia was defined as a heart rate 190 beats/minute in children aged <12 months
and heart rate140 beats/minute in children aged12months. Tachypneawas defined as respiratory rate >50 breaths/minute for children aged 2e11months and respiratory
rate >40 breaths/minute for children aged 12 months.













Age in months, mean (SD) 41.3 (15.2) 20.0 (14.6) 30.4 (18.2) 10.1 (10.1) 24.7 (16.9) <0.001
Number < 12 months (%) 30 (13) 168 (37) 33 (25) 77 (75) 44 (31) <0.001
Number of boys (%) 117 (51) 258 (57) 87 (65) 46 (35) 88 (62) 0.058
Clinical characteristics
Symptoms, n (%)
Cough 0 (0) 453 (100) 130 (98) 103 (100) 138 (97) <0.001
Difficulty breathing 0 (0) 416 (92) 118 (89) 91 (88) 71 (50) <0.001
Rhinorrhea 0 (0) 376 (83) 107 (80) 83 (81) 123 (86) <0.001
Fever 0 (0) 348 (77) 69 (52) 57 (55) 55 (38) <0.001
Diarrhea 0 (0) 96 (21) 19 (14) 23 (22) 16 (11) <0.001
Chest indrawing, n (%) 0 (0) 203 (45) 48 (36) 48 (46) 1 (1) <0.001
Temperature, mean (SD) 36.4 (0.4) 36.9 (0.7) 36.9 (0.6) 36.8 (0.6) 36.7 (0.6) <0.001
Number with 38.0 C (%) 1 (0) 48 (11) 9 (7) 8 (8) 8 (6) <0.001
Heart Rate
Infants, mean (SD) 122 (14) 138 (17) 127 (19) 135 (17) 133 (15)
Children, mean (SD) 107 (10) 129 (18) 127 (17) 129 (18) 114 (16)
Number with tachycardia (%) 3 (1) 89 (20) 22 (17) 7 (7) 8 (6) <0.001
Respiratory Rate
Infants, mean (SD) 29 (4) 45 (11) 46 (13) 44 (13) 35 (11)
Children, mean (SD) 23 (3) 39 (11) 36 (11) 42 (13) 27 (6)
Number with tachypnea (%) 1 (0) 203 (45) 43 (32) 42 (41) 13 (9) <0.001
Oxyhemoglobin Saturation (SpO2) %,
mean (SD)
99 (1) 96 (3) 96 (3) 97 (2) 99 (2)
Number with SpO2 <95% (%) 1 (0) 47 (10) 18 (14) 7 (7) 1 (1)
Number with SpO2 <92% (%) 1 (0) 175 (39) 51 (38) 23 (22) 10 (7) <0.001
Auscultation findings, n (%)
Normal 230 (100) 2 (0) 1 (1) 0 (0) 74 (52) <0.001
Wheezes 0 (0) 200 (44) 100 (75) 65 (63) 8 (6) <0.001
Crackles 0 (0) 335 (74) 53 (40) 50 (49) 7 (5) <0.001
Decreased breath sounds 0 (0) 80 (19) 13 (10) 4 (4) 1 (1) <0.001
Rhonchi 0 (0) 157 (35) 42 (32) 46 (45) 9 (6) <0.001
Table 3
Lung ultrasound diagnosis and characteristics.












Procedure time in minutes,
mean (SD)
5.5 (2.1) 8.2 (3.1) 7.2 (2.5) 7.5 (2.6) 5.9 (4.2) <0.001
Normal ultrasound, n (%) 219 (95) 93 (21) 67 (50) 36 (35) 107 (75) <0.001
Large Consolidation 0 (0) 127 (28) 3 (2) 8 (8) 0 (0) <0.001
Shred sign 0 (0) 24 (19) 0 (0) 2 (25) 0 (0) 0.81
Air Bronchogram 0 (0)
Pleural Abnormalities 0 (0) 23 (18) 2 (67) 3 (38) 0 (0) 0.03
Pleural Effusion 0 (0) 22 (17) 1 (33) 1 (13) 0 (0) 0.64
Interstitial Findings 0 (0)
Small Consolidation 0 (0) 175 (39) 46 (35) 41 (40) 15 (10) <0.001
Shred sign 0 (0) 35 (20) 0 (0) 5 (12) 7 (47) <0.001
Air Bronchogram 0 (0)
Pleural Abnormalities 0 (0) 59 (34) 18 (19) 14 (34) 2 (13) 0.34
Pleural Effusion 0 (0) 1 (1) 1 (2) 0 (0) 0 (0) 0.60
Interstitial Findings 0 (0)
Focal Interstitial syndrome 9 (4) 43 (9) 8 (6) 10 (10) 13 (9) 0.09
Diffuse Interstitial syndrome 1 (0) 9 (2) 5 (4) 6 (6) 4 (3) 0.02
Pleural abnormalities only 1 (0) 6 (1) 4 (3) 2 (2) 4 (3) 0.26
Table 4
Definitions and values for analysis of diagnostic Accuracy.





















Any abnormality on lung
ultrasound
421 176 219 11 15
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five years and performed all testing in a busy tertiary care hospital
in a resource-limited setting, suggesting that LUS can be realisti-
cally implemented in high-volume clinical settings without major
disruptions to work flow. To our knowledge, this study is the first to
examine reproducibility of LUS between multiple readers, using a
standardized approach for the conduct of LUS. We provided specific
details of sonographic findings, separating minimal pleural abnor-
malities and interstitial B-lines from large consolidations. Further-
more, we performed LUS evaluation on participants with a breadth
of diverse respiratory pathologies including a group of children
without respiratory symptoms. This differs from prior research that
only focused on pneumonia without including healthy children or
those with other respiratory disease processes, with the exception
of Caiulo et al. who also studied bronchiolitis [33]. While not part of
the reference standard for diagnosis, ancillary laboratory testing
provided additional confidence to our diagnoses. Procalcitonin has
previously been shown to be elevated in bacterial disease [34] and
was highest in children with radiographically-confirmed pneu-
monia when compared to children who did not. The proportion of
children with respiratory syncytial virus was greatest among chil-
dren with bronchiolitis than among those with pneumonia, which
is consistent with previous epidemiologic studies [24]. However, a
limitation to the use of pharyngeal swabs is evident because there
we did not find a no difference in the prevalence of S. pneumoniae
between children with or without respiratory symptoms.
Our study has some potential shortcomings. First, we did not
have computerized tomography (CT) scan on all children with
respiratory findings but standard of care would have not directed
the use of CT scans to diagnose pneumonia in children. We used
radiographically-confirmed clinical pneumonia as our gold stan-
dard, despite its limitations, which we believe is the safest alter-
native to the current gold-standard. As such, we were unable to
arbitrate differences between LUS and CXR findings. LUS cannot
detect consolidations that do not reach the pleura, whereas small
consolidations (<1 intercostal space) observed on LUS cannot be
visualized on CXR [27]. Nonetheless, the clinical relevance of small
consolidations of LUS remains uncertain. Moreover, retrocardiac
opacifications or consolidations may not be easily visualized on
antero-posterior CXRs when compared to LUS. Second, we did not
have information on the time course or severity of illness. Specif-
ically, we did not follow the clinical course and had imaging only at
the time of enrollment. Third, LUS may not be able to differentiate
between small alveolar abnormalities and atelectasis. While Lich-
tenstein et al. described that, in adults, dynamic air bronchograms
were more likely to occur in pneumonia whereas static air bron-
chograms were more likely to occur in atelectasis [35], recognition
of dynamic air bronchograms is difficult in children because of their
body size. Fourth, overall sensitivity of LUS for the diagnosis of
radiographically-confirmed pneumonia was lower than previously
reported [15,16]. However, this may be in part due to selection bias
in previous studies where participants may have been more likely
to have severe pneumonia. It might also be due to probe placement
in our study: we did not consistently utilize transverse views,
which may improve the diagnostic yield in children [17]. Fifth, the
Table 5
Analysis of diagnostic Accuracy.
Analysis PPV NPV Sensitivity Specificity AUC (95% CI)
Radiographically-Confirmed Clinical Pneumonia vs. finding a consolidation on lung ultrasound 100 91.3 88.5 100 0.94 (0.92e0.97)
Radiographically-Confirmed Clinical Pneumonia vs. finding any abnormality on lung ultrasound 94.1 93.6 92.2 95.2 0.94 (0.91e0.96)
Table 6
Laboratory evaluation in subset of participants.
Children without respiratory symptoms Pneumonia Asthma Bronchiolitis Upper respiratory infection P value
Blood cell count
Sample size 54 138 54 49 66
Hemoglobin (mg/dl), mean (SD) 10.9 (1.3) 10.6 (1.3) 10.8 (1.7) 10.8 (1.4) 10.7 (1.4) 0.79
Number with <11 mg/dL (%) 26 (49) 56 (41) 26 (48) 19 (39) 29 (44) 0.74
Platelets x 103/L, mean (SD) 420 (136) 414 (146) 405 (124) 460 (130) 421 (136) 0.28
White blood cells x 103/L, mean (SD) 11.9 (5.5) 11.7 (5.1) 13.8 (6.7) 13.0 (6.0) 13.1 (5.0) 0.08
Number with >17  103/L (%) 8 (15) 20 (15) 13 (24) 7 (15) 16 (25) 0.26
Throat swabs result
Sample size 32 32 41 46 50
Respiratory virus, n (%)
Any positive virus 4 (13) 29 (35) 18 (44) 23 (50) 11 (22) 0.002
Viral etiology
Respiratory Synctitial Virus 0 (0) 12 (18) 8 (26) 14 (38) 4 (9) <0.001
Adenovirus 3 (10) 6 (10) 6 (21) 1 (4) 4 (9) 0.45
Parainfluenza 1-3 0 (0) 5 (9) 2 (8) 5 (18) 1 (3) 0.07
Metapneumovirus 1 (3) 5 (9) 1 (4) 2 (8) 1 (3) 0.77
Influenza virus 0 (0) 2 (4) 1 (4) 0 (0) 2 (5) 0.79
Coronavirus 0 (0) 0 (0) 0 (0) 2 (8) 0 (0) 0.04
Bacteria and Candida
Any positive 32 (100) 79 (96) 36 (88) 42 (91) 50 (100) 0.03
Microorganism etiology
Streptococcus pneumoniae 18 (56) 52 (63) 27 (66) 30 (65) 33 (66) 0.91
Candida albicans 2 (6) 6 (7) 2 (5) 9 (20) 7 (14) 0.11
Haemophilus influenzae 1 (3) 6 (7) 0 (0) 2 (4) 2 (4) 0.45
Moraxella catarrhalis 1 (3) 2 (2) 0 (0) 1 (2) 1 (2) 0.89
Neisseria meningitidis 1 (3) 1 (1) 1 (2) 1 (2) 0 (0) 0.80
Procalcitonin, ng/ml
Sample size 28 113 50 27 41
Median (IQR) 0.01 (0.00e0.03) 0.14 (0.06e0.55) 0.06 (0.04e0.08) 0.06 (0.04e0.09) 0.06 (0.04e0.11) <0.001
Geometric mean (95% CI) 0.03 (0.03e0.04) 0.19 (0.15e0.25) 0.07 (0.06e0.09) 0.07 (0.05e0.09) 0.08 (0.06e0.10) <0.001
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study physician conducting the ultrasound was not blinded to
visible clinical symptoms, which may induce them to spend longer
conducting LUS on children that appear more ill. Sixth, the kappa
for agreement for CXR in our study was lower that what is previ-
ously found [36,37]. This may be due lack of adherence to the WHO
guidelines for reading CXRs, poor quality of the CXR and variability
of respiratory illness in our study population.
LUS is a promising tool that offers portability and diagnostic
accuracy in resource-limited settings. It has the added benefits of
rapid testing and appears to be easily taught. These results offer
promise and may help improve the specificity of case management
algorithms for the diagnosis of pediatric pneumonia. Future
research should focus on prospective randomized trials using LUS
as part of the case management algorithm for acute lower respi-
ratory infections. Moreover, with prospective follow-up, we may
better understand the evolution of LUS findings over time and
determine whether early diagnosis using LUS may translate into
clinically meaningful outcomes. Through increased development
and production of high performance, portable devices, and stan-
dardized training modules, LUS could be a cost-effective solution to
improve the diagnosis and management of pediatric pneumonia in
appropriate settings worldwide.
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